Lesabelimab

Tax included
Lesabelimab (LDP) is an immunoglobulin G1-kappa anti-CD274 monoclonal antibody. CD274 is an immune checkpoint ligand, represses antitumour immunity through the interaction with PDCD1 receptor.
HY-P99698

Data sheet

Size
Multiple sizes
Reactivity
Others
CAS
2475402-56-1